TITLE

Adult Stem Cells--Real Hope for the Future, Real Help for Patients Now

AUTHOR(S)
Prentice, David A.
PUB. DATE
January 2011
SOURCE
National Right to Life News;Jan2011, Vol. 38 Issue 1, p5
SOURCE TYPE
Periodical
DOC. TYPE
Article
ABSTRACT
This article looks forward to the future of research on embryonic stem cell. It criticizes embryonic stem cell research for not helping a single patient. It also offers an overview of three experimental trials approved in the U.S. that propose to utilize derivatives of embryonic stem cells to treat spinal cord injury or blindness. The use of adult stem cells in the treatment of multiple sclerosis is also suggested.
ACCESSION #
57671465

 

Related Articles

  • Adult Stem Cell Treatment for Spinal Cord Injury Shows Promise. Townsend, Liz // National Right to Life News;Aug2006, Vol. 33 Issue 8, p1 

    The article focuses on the findings of a study conducted by Doctor Carlos Lima that shows that a treatment that transplants patients' own nasal stem cells to the site of a spinal cord injury can renew the sensation and motor control of paralyzed patients. The study is being ignored by the media...

  • Selling Out for Science. Guterl, Fred; Cunningham, Jaime; Raymond, Joan; Brownell, Ginanne // Newsweek (Pacific Edition);11/8/2004 (Pacific Edition), Vol. 144 Issue 19, p46 

    Focuses on the debate over stem cells in the United States. Claim that some scientists have exaggerated stem cells' potential for cures; Reference to a proposition in California that would give $3 billion to human embryonic stem cell research; Research conducted by Hans Kierstead of the...

  • Stem Cell Tourism. Cook, Michael // Australasian Science;Oct2011, Vol. 32 Issue 8, p48 

    The article discusses the issue whether stem cells can be used as a therapy for diabetes and hair loss. It notes the cases in which bovine cells or unsorted tissue slurries from human fetal brain are given by unscrupulous clinics to patients. It clarifies that scientists badly sold stem cells to...

  • Selling Out for Science. Guterl, Fred; Cunningham, Jaime; Raymond, Joan; Brownell, Ginanne // Newsweek (Atlantic Edition);11/8/2004 (Atlantic Edition), Vol. 144 Issue 19, p54 

    Focuses on the debate over stem cells in the United States. Claim that some scientists have exaggerated stem cells' potential for cures; Reference to a proposition in California that would give $3 billion to human embryonic stem cell research; Research conducted by Hans Kierstead of the...

  • Consent to the use of aborted fetuses in stem cell research and therapies. Pfeffer, N.; Kent, J. // Clinical Ethics;2006, Vol. 1 Issue 4, p216 

    This paper identifies the legal and policy framework relating to the use of aborted fetuses in stem cell research and therapies and contrasts this with the collection of embryos for research. It suggests that more attention should be given to questions about the kind of consent sought by...

  • BrainStorm Cell Therapeutics Expands Pipeline with the Initiation of a Study for Multiple Sclerosis.  // Biomedical Market Newsletter;3/21/2012, Vol. 21, p1 

    The article offers information on the initiation of a preclinical study by BrainStorm Cell Therapeutics Inc. for evaluating efficacy of NurOwn stem cell technology in treatment of Multiple Sclerosis. Positive proof of concept results has been obtained by the company for the stem cell technology...

  • Direct Reprogramming. Marb├ín, Eduardo; Cingolani, Eugenio // JAMA: Journal of the American Medical Association;7/7/2015, Vol. 314 Issue 1, p19 

    The authors comment on the direct reprogramming of stem cells for therapeutics. Topics covered include concerns that have restricted in vivo applications of tissues and organs to be recreated from embryonic stem cells, the limitations of induced stem cells as well as the complexity of...

  • Geron Exit a Symbolic Ding' for Stem-Cell Research.  // MondayMorning;11/21/2011, Vol. 19 Issue 42, p3 

    The article discusses the withdrawal by Geron Corp. of Menlo Park, California from its study of a stem cell-based treatment for spinal cord injury. It notes that Geron was viewed as the undisputed leader in stem-cell therapies and have helped finance researchers at the University of Wisconsin...

  • Spheroid Formation and Neural Induction in Human Adipose-Derived Stem Cells on a Chitosan-Coated Surface. Hsueh, Yuan-Yu; Chiang, Yi-Lun; Wu, Chia-Ching; Lin, Sheng-Che // Cells Tissues Organs;2012, Vol. 196 Issue 2, p117 

    The application of stem cells appears to have great therapeutic potential to facilitate nerve regeneration in patients with neurodegenerative disease or spinal cord injury. Human adipose-derived stem cells (hADSCs), a subset of multipotent mesenchymal stem cells, possess the great advantages of...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics